首页> 外文期刊>Cancer Chemotherapy and Pharmacology >SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors
【24h】

SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors

机译:SCH 1473759是一种新型的Aurora抑制剂,与紫杉烷类药物和KSP抑制剂联合使用具有增强的抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Aurora kinases are required for orderly progression of cells through mitosis, and inhibition of these kinases by siRNA or small molecule inhibitors results in cell death. We previously reported the synthesis of SCH 1473759, a novel sub-nanomolar Aurora A/B inhibitor.
机译:目的Aurora激酶是通过有丝分裂使细胞有序发展所必需的,而siRNA或小分子抑制剂抑制这些激酶会导致细胞死亡。我们之前曾报道过SCH 1473759的合成,这是一种新型的亚纳摩尔Aurora A / B抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号